Biochemical Engineering

Biochemical Engineering is a highly interdisciplinary field combining biotechnology and chemical engineering. It includes the study of how basic raw materials are changed to the finished products by means of rigorous processes. It mainly deals with the design, construction, and advancement of unit processes that involve biological organisms or organic molecules and has different applications in areas of interest like biofuels, food, pharmaceuticals, biotechnology and water treatment processes. The cells could be from animals, bacteria or single-celled animals like algae each type needs to be treated in a various way to get them to do what is needed.

  • Biofuels
  • Medicines
  • Personal care products
  • Cleaning products
  • Paper
  • Plastic products
  • Oil products
  • Paint products
  • Pesticides

Comments

Post a Comment

Popular posts from this blog

Medical Biotechnology

Image
Medical biotechnology   is a branch of medicine that uses living cells and cell materials to research and then produce pharmaceutical and diagnosing products. These products help treat and prevent diseases. The main aim of medical biotechnology is the Prevention, Diagnosis and Treatment of diseases. Medical Biotechnology principles are applied in   pharmacology , gene therapy, stem cells and tissue engineering. It is a rapidly evolving field integrating knowledge obtained in molecular, cell biological, genetic and immunological scientific areas. The medical biotechnology field has helped bring to market microbial pesticides, insect-resistant crops, and environmental clean-up techniques. This discovery was the result of research studies related to deoxyribonucleic acid. Many scientists in the medical   biotechnology   field study genetic engineering which involves isolating, identifying and sequencing the human genes to determine their functions. Advancements- CRISPR Tissue Nanotransfec
Read more

Beyond vaccines: emerging technologies capable of unlocking the promise of biologically targeted mRNA therapeutics

Image
Immunization requires minimal protein expression levels, while mRNA therapeutics requires a 1,000-fold-higher protein level to reach a therapeutic threshold. Efficient delivery to solid organs remains challenging. Even the tissue bioavailability, circulatory half-life, and efficiency of the LNP-based carrier could be rate-limiting when it is delivered to the target tissue. Even with optimized mRNA chemical modifications and advanced LNPs, chronic dosing eventually activates innate immunity, parallelly attenuating therapeutic protein expression. An individual mRNA has a cap, 5′ and 3′ untranslated regions (UTRs), an open reading frame (ORF), and a polyadenylated (poly(A)) tail. There have been advancements in the design of each of these components. Most notable of these are: i) improved 5′ cap analogs that enhance translational capacity, but more importantly, the capping efficiency from 70% to 95%. ii) the poly(A) tail length optimization has proven critical for balancing the synthetic
Read more